Aceso Life Science Group Limited

SEHK:474 Stock Report

Market Cap: HK$391.2m

Aceso Life Science Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure8.1yrs
Board average tenure11.8yrs

Recent management updates

Recent updates

Is Aceso Life Science Group Limited (HKG:474) Popular Amongst Insiders?

Feb 23
Is Aceso Life Science Group Limited (HKG:474) Popular Amongst Insiders?

Have Insiders Sold Aceso Life Science Group Limited (HKG:474) Shares Recently?

Jan 01
Have Insiders Sold Aceso Life Science Group Limited (HKG:474) Shares Recently?

CEO

Aceso Life Science Group has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Chi Tak Fok
CFO & Executive Director14yrsHK$5.00m0.82%
HK$ 3.2m
Shao Yu Li
Senior Consultant9.3yrsHK$13.20m57.5%
HK$ 224.9m
Zhiliang Ou
Executive Directorno dataHK$600.00k0.0099%
HK$ 38.9k
Xiaodong Liu
Chief Operating Officer6.3yrsno datano data
Chun Mo Law
Group Financial Controller8.1yrsno datano data
Chun Pong Siu
Company Secretary2.3yrsno datano data

8.1yrs

Average Tenure

51yo

Average Age

Experienced Management: 474's management team is seasoned and experienced (8.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Chi Tak Fok
CFO & Executive Director11.3yrsHK$5.00m0.82%
HK$ 3.2m
Zhiliang Ou
Executive Director12.5yrsHK$600.00k0.0099%
HK$ 38.9k
Kwan Sing Lam
Independent Non-Executive Director12.3yrsHK$200.00k0.0099%
HK$ 38.9k
Ming Sun Chan
Independent Non-Executive Director12.8yrsHK$200.00k0.0099%
HK$ 38.9k
Yiu Tong Mak
Independent Non-Executive Director3.4yrsHK$200.00kno data
Yang Jiang
Non-Executive Directorno datano datano data

11.8yrs

Average Tenure

53yo

Average Age

Experienced Board: 474's board of directors are seasoned and experienced ( 11.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:35
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aceso Life Science Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin WangGuotai Junan International Holdings Limited